Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Caroline Buors"'
Autor:
Léa Sureau, Caroline Buors, Jean-Christophe Ianotto, Françoise Boyer, Aline Tanguy-Schmidt, Lydia Roy, Emilie Cayssials, Laura Cailly, Jean-Claude Chomel, Aurélie Chauveau, Corentin Orvain, Olivier Mansier, Dana Ranta, Margot Robles, Emmanuel Gyan, Olivier Hérault, Stanislas Nimubona, Tony Marchand, Eric Lippert, Jérémie Riou, Valérie Ugo, Damien Luque Paz
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 4, Pp 1-5 (2022)
Externí odkaz:
https://doaj.org/article/b35aa590cbca43aabd6966fa3cb80813
Autor:
Jean-Richard Eveillard, Hélène Kerspern, Eric Lippert, Nicolas Galakhoff, Cyril Leven, Jean-Luc Carré, Maël Padelli, Caroline Buors, Cécile Aubron, Adrian Tempescul
Publikováno v:
Biochemia Medica
Volume 30
Issue 1
Biochemia Medica, 2019, 30 (1), pp.010801. ⟨10.11613/BM.2020.010801⟩
Volume 30
Issue 1
Biochemia Medica, 2019, 30 (1), pp.010801. ⟨10.11613/BM.2020.010801⟩
International audience; This is a case report of a challenging diagnosis of IgE monoclonal gammopathy of undetermined significance, which transformed into myeloma, then transformed into IgE-producing plasma cell leukaemia in a 71-year-old male who wa
Autor:
Caroline Buors, Laura Samaison, Aurélie Chauveau, Paul Gueguen, Valérie Seegers, Damien Luque Paz, Cédric Le Maréchal, Françoise Boyer, Laurane Cottin, Jean-Christophe Ianotto, Eric Lippert, Claude Férec, Valérie Ugo
Publikováno v:
Genes, Chromosomes and Cancer. 56:354-362
Philadelphia-negative classical myeloproliferative neoplasms (MPN) are clonal diseases characterized by driver mutations of JAK2, MPL, or CALR. Additional mutations may occur in epigenetic regulators, signaling, or splicing genes that may be useful i
Autor:
Christian Berthou, Gaelle Guillerm, Jean-Christophe Ianotto, Pascal Delépine, Chloé Henry, Caroline Buors, Christophe Nicol, Marie-Anne Couturier, Céline Tripogney, Adrian Tempescul
Publikováno v:
Leukemia & lymphoma
Leukemia & lymphoma, 2017, 58 (9), pp.1-3. ⟨10.1080/10428194.2017.1285025⟩
Leukemia & lymphoma, Taylor & Francis, 2017, 58 (9), pp.1-3. ⟨10.1080/10428194.2017.1285025⟩
Leukemia & lymphoma, 2017, 58 (9), pp.1-3. ⟨10.1080/10428194.2017.1285025⟩
Leukemia & lymphoma, Taylor & Francis, 2017, 58 (9), pp.1-3. ⟨10.1080/10428194.2017.1285025⟩
RhuG-CSF reduces the duration of neutropenia induced by chemotherapies. The most frequent drug used for this indication is filgrastim (initially Neupogen®-AMGEN SA). Filgrastim biosimilars have bee...
Autor:
Caroline Buors, Mehdi Sakka, Christian Berthou, Eric Lippert, Isabelle Quintin-Roué, Gaelle Guillerm, Jean-Luc Carré, Jean-Richard Eveillard, Hélène Kerspern, Jean-Christophe Ianotto, Ahmed Meskar, Lenaïg Le Clech
Publikováno v:
Leukemia & lymphoma
Leukemia & lymphoma, Taylor & Francis, 2017, pp.1-6
Leukemia & lymphoma, Taylor & Francis, 2017, pp.1-6
International audience; Many case reports have indicated the occurrence of monoclonal gammopathy of uncertain significance (MGUS) or multiple myeloma (MM) in patients with Ph-negative myeloproliferative neoplasms (MPN), but few cohorts of patients ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0dbf2f50304d6473b63a393ba9e44d9
https://hal.archives-ouvertes.fr/hal-01529175
https://hal.archives-ouvertes.fr/hal-01529175
Autor:
Marjolaine Debant, Cristina Bagacean, Sophie Hillion, B. Bendaoud, Yves Renaudineau, Catherine Riou, Caroline Buors, Christian Berthou, Adrian Tempescul
Publikováno v:
European Journal of Haematology
European Journal of Haematology, Wiley, 2015, 96 (3), pp.229-35
European Journal of Haematology, Wiley, 2015, 96 (3), pp.229-35
International audience; The management of patients with chronic lymphocytic leukaemia (CLL) has improved with the utilisation of ofatumumab as a novel anti-CD20 monoclonal antibody. However, as half of the patients fail to respond to the treatment, t
Autor:
Jean-Christophe Ianotto, Caroline Buors, Claude Férec, Laura Samaison, Aurélie Chauveau, Cédric Le Maréchal, Françoise Boyer, Valérie Ugo, Damien Luque Paz, Paul Gueguen
Publikováno v:
Blood. 126:2808-2808
Introduction Myeloproliferative neoplasms (MPN) are molecularly characterized by driver mutations of JAK2, MPL or CALR. Other somatic mutations may occur in epigenetic modifiers or oncogenes. Some of them have been shown to confer a poor prognosis in
Autor:
Rémi Marianowski, Valérie Devauchelle, Christelle Le Dantec, Séverine Loisel, Jacques-Olivier Pers, Caroline Buors, Yves Renaudineau, Pierre Youinou, Alain Saraux, Sophie Hillion, Ruby Alonso, Enrique Montero
Publikováno v:
Journal of Autoimmunity
Journal of Autoimmunity, Elsevier, 2010, 35 (4), pp.336-41. ⟨10.1016/j.jaut.2010.07.005⟩
Journal of Autoimmunity, Elsevier, 2010, 35 (4), pp.336-41. ⟨10.1016/j.jaut.2010.07.005⟩
International audience; CD6 is one of a pair of related genes encoding CD5-associated receptors on all T cells and a subset of B cells. The current availability of "T1h", a humanized anti-CD6 monoclonal antibody for B cell-mediated autoimmune disorde
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7ab8fd5a72c641bbd90d9d508dca0fa
https://hal.univ-brest.fr/hal-01066162
https://hal.univ-brest.fr/hal-01066162
Autor:
Pierre Youinou, Séverine Loisel, Yves Renaudineau, Jacques-Olivier Pers, Enrique Montero, Caroline Buors, Ruby Alonso-Ramirez
Publikováno v:
Arthritis
Arthritis, Hindawi Publishing Corporation, 2010, 2010, pp.130646. ⟨10.1155/2010/130646⟩
Arthritis, Vol 2010 (2010)
Arthritis, Hindawi Publishing Corporation, 2010, 2010, pp.130646. ⟨10.1155/2010/130646⟩
Arthritis, Vol 2010 (2010)
CD6 is a 105–130 kDa surface glycoprotein expressed on the majority of T cells and a subset of B cells. The human cd6 gene maps to chromosome 11, and the expression of its protein product is tightly regulated. CD6 mediates cellular adhesion migrati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a88b2bac2fd40c7d8835158a6e383023
https://hal.univ-brest.fr/hal-01066129
https://hal.univ-brest.fr/hal-01066129
Autor:
Caroline Buors, Françoise Boyer, Aline Tanguy-Schmidt, Aurélie Chauveau, Lydia Roy, Jean-Claude Chomel, Thierry Lamy, Olivier Fardel, Olivier Herault, Laura Samaison, Valérie Ugo, Jean-Christophe Ianotto
Publikováno v:
Blood. 122:1593-1593
Introduction The JAK2 V617F mutation is present in almost all Polycythemia Vera (PV) and in 60-70% of Essential Thrombocythemia (ET) cases. There are experimental evidences that this acquired clonal driving mutation is involved in disease phenotype i